Reference
Da Fonseca AR, et al. Subcutaneous alemtuzumab has activity in treatment-naive patients with acquired aplastic anemia. Blood 134 (Suppl. 1): Nov 2019. Available from: URL: https://doi.org/10.1182/blood-2019-130719 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1787, 25 (2020). https://doi.org/10.1007/s40278-020-73663-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-73663-y